Track topics on Twitter Track topics that are important to you
The potential impact of drugs on cognition is becoming increasingly important to regulators, physicians and patients, yet few drug developers have robust cognitive assessment protocols. Find out how computerized delivery of objective and sensitive assessments can enhance the clinical development process in this free webinar.
TORONTO (PRWEB) May 21, 2019
Regulators, physicians and patients are all concerned by the potential impact of new drugs on cognition, as any drug that crosses the blood-brain barrier (BBB) can have detrimental effects.
Common disease states, environmental toxins, certain medications and the aging process itself can all compromise the integrity of the BBB. Accordingly, both central nervous system (CNS) and non-CNS therapeutics (e.g. for cardiovascular disease, diabetes, cancer, pain) can present significant challenges for cognitive safety in their target patient populations.
Consequently, recent regulatory guidance recognises the critical importance of monitoring cognitive function throughout the drug development process in order to adequately assess the safety and risk profile of new compounds, and make appropriate label claims.
Join Kenton Zavitz, PhD, Director of Clinical Affairs at Cambridge Cognition in a live webinar on Wednesday, June 5, 2019 at 11am EDT (4pm BST/UK) to learn how the computerized delivery of objective and sensitive cognitive assessments can enhance the clinical development process. These assessments facilitate early decision-making, profile safety and tolerability and satisfy current regulatory requirements in an increasingly challenging and competitive pharmaceutical landscape.
This webinar is suitable for biopharmaceutical researchers and CRO professionals who are working in:
For more information or to register for this event, visit Cognitive Safety: Satisfying Regulatory Requirements in a Competitive Landscape.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
For the original version on PRWeb visit: https://www.prweb.com/releases/cognitive_safety_satisfying_regulatory_requirements_in_a_competitive_landscape_upcoming_webinar_hosted_by_xtalks/prweb16322195.htmNEXT ARTICLE
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...